116
Participants
Start Date
April 30, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Milnacipran
"Maximum tolerated dose (50, 75, or 100 mg/day tablets) was determined during the open label phase of the study.~Oral administration, twice daily dosing"
Placebo
matching placebo tablets daily
Forest Investigative Site 066, Mechanicsburg
Forest Investigative Site 054, Philadelphia
Forest Investigative Site 021, Lynchburg
Forest Investigative Site 052, Winston-Salem
Forest Investigative Site 062, Raleigh
Forest Investigative Site 046, Greer
Forest Investigative Site 058, Blue Ridge
Forest Investigative Site 031, Savannah
Forest Investigative Site 061, Gainesville
Forest Investigative Site 041, Orange City
Forest Investigative Site 059, Orlando
Forest Investigative Site 055, West Palm Beach
Forest Investigative Site 014, Spring Hill
Forest Investigative Site 040, Birmingham
Forest Investigative Site 068, Birmingham
Forest Investigative Site 017, Louisville
Forest Investigative Site 019, Middleburg Heights
Forest Investigative Site 038, Akron
Forest Investigative Site 016, Cincinnati
Forest Investigative Site 015, Dayton
Forest Investigative Site 005, Indianapolis
Forest Investigative Site 009, Ann Arbor
Forest Investigative Site 024, Rochester Hills
Forest Investigative Site 036, Stevensville
Forest Investigative Site 004, Racine
Forest Investigative Site 022, Chicago
Forest Investigative Site 010, Peoria
Forest Investigative Site 001, Oklahoma City
Forest Investigative Site 027, Oklahoma City
Forest Investigative Site 003, San Antonio
Forest Investigative Site 042, San Antonio
Forest Investigative Site 023, Austin
Forest Investigative Site 034, Colorado Springs
Forest Investigative Site 025, Clinton
Forest Investigative Site 013, Salt Lake City
Forest Investigative Site 033, Bullhead City
Forest Investigative Site 018, Albuquerque
Forest Investigative Site 035, Orange
Forest Investigative Site 053, Orange
Forest Investigative Site 012, Fresno
Forest Investigative Site 045, Fresno
Forest Investigative Site 051, Fresno
Forest Investigative Site 050, Sacramento
Forest Investigative Site 006, Bellevue
Forest Investigative Site 063, Seattle
Forest Investigative Site 047, Cromwell
Forest Investigative Site 049, Whitehouse Station
Lead Sponsor
Collaborators (1)
Cypress Bioscience, Inc.
INDUSTRY
Forest Laboratories
INDUSTRY